Application Note: IMAP Phosphodiesterase Assays on SpectraMax Multi-Mode Microplate Readers
3 February 2019

IMAP® Technology from Molecular Devices enables rapid, homogeneous, and non-radioactive assay of kinases, phosphatases, and phosphodiesterases and is suited for both assay development and high-throughput screening. IMAP assays are based on binding of phosphate to immobilized metal coordination complexes on nanoparticles.